Train Babcock Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Train Babcock Advisors's XBI Position: Q4 2017 in Review
Train Babcock Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q4 2017: 9,595 shares worth $815K. The stake represents 0.36% of the portfolio and ranks #57 among its holdings. This is a return to the name: Train Babcock Advisors previously reported a position in XBI as recently as Q2 2017.
Train Babcock Advisors first reported a position in XBI in Q2 2017 and has held it in 2 quarters since. 397 funds tracked by Wall St. Rank hold XBI as of Q4 2017.
- Train Babcock Advisors held 9,595 shares of State Street SPDR S&P Biotech ETF worth $815K as of Q4 2017.
- State Street SPDR S&P Biotech ETF was a new Train Babcock Advisors position in Q4 2017.
- State Street SPDR S&P Biotech ETF made up 0.36% of Train Babcock Advisors's portfolio in Q4 2017, its #57 holding.
- Train Babcock Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q2 2017 and has held it in 2 quarters since.
- 397 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2017.
Based on Train Babcock Advisors's 13F filing for Q4 2017, filed 10 Jan 2018.